Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant.
Beitinjaneh AM, Saliba R, Bashir Q, Shah N, Parmar S, Hosing C, Popat U, Anderlini P, Dinh Y, Qureshi S, Rondon G, Champlin RE, Giralt SA, Qazilbash MH.
Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]
Related citations
BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response.
Simara P, Peterkova M, Stejskal S, Potesilova M, Koutna I, Racil Z, Razga F, Jurcek T, Dvorakova D, Mayer J.
Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print] No abstract available.
Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma.
Campbell P, Friebe A, Foulstone P, Grigg A, Hempton J, Bajel A.
Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.
Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors.
Telio D, Fernandes K, Ma C, Tsang R, Keating A, Crump M, Kuruvilla J.
Leuk Lymphoma. 2012 May;53(5):836-41.
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.
Goldberg JD, Chou JF, Horwitz S, Teruya-Feldstein J, Barker JN, Boulad F, Castro-Malaspina H, Giralt S, Jakubowski AA, Koehne G, van den Brink MR, Young JW, Zhang Z, Papadopoulos EB, Perales MA.
Leuk Lymphoma. 2012 Jun;53(6):1124-9. Epub 2012 Jan 31.
Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center.
Anderlini P, Saliba R, Acholonu S, Okoroji GJ, Ledesma C, Andersson BS, Jones R, Popat UR, Hosing CM, Nieto Y, Qazilbash MH, Ueno NT, Giralt SA, de Lima MJ, Champlin RE.
Leuk Lymphoma. 2012 Jun;53(6):1239-41. Epub 2012 Jan 5. No abstract available.
Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.
Lane AA, Armand P, Feng Y, Neuberg DS, Abramson JS, Brown JR, Fisher DC, Lacasce AS, Jacobsen ED, McAfee SL, Spitzer TR, Freedman AS, Chen YB.
Leuk Lymphoma. 2012 Jun;53(6):1130-6. Epub 2012 Jan 3.
Upfront thiotepa, busulfan, cyclophosphamide, and autologous stem cell transplantation for primary CNS lymphoma: a single centre experience.
Alimohamed N, Daly A, Owen C, Duggan P, Stewart DA.
Leuk Lymphoma. 2012 May;53(5):862-7. Epub 2011 Dec 6.
High-dose therapy and autologous stem cell transplant for transformed non-Hodgkin lymphoma in the rituximab era.
Ban-Hoefen M, Kelly JL, Bernstein SH, Liesveld J, Constine L, Becker M, Milner L, Phillips G, Friedberg JW.
Leuk Lymphoma. 2012 May;53(5):830-5. Epub 2011 Dec 6.
Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.
Eom KS, Kim HJ, Cho BS, Choi SM, Lee DG, Lee SE, Yahng SA, Kim YJ, Lee S, Min CK, Cho SG, Kim DW, Lee JW, Park CW, Min WS.
Leuk Lymphoma. 2011 Dec;52(12):2321-8. Epub 2011 Oct 24.
Haploidentical hematopoietic stem cell transplantation in hematologic malignancies with G-CSF mobilized bone marrow plus peripheral blood stem cells grafts without T cell depletion: a single center report of 29 cases.
Wang HX, Yan HM, Wang ZD, Xue M, Liu J, Guo ZK.
Leuk Lymphoma. 2012 Apr;53(4):654-9. Epub 2011 Dec 5.
Double high-dose therapy with dose-intensive cyclophosphamide, etoposide, cisplatin (DICEP) followed by high-dose melphalan and autologous stem cell transplantation for relapsed/refractory Hodgkin lymphoma.
Shafey M, Duan Q, Russell J, Duggan P, Balogh A, Stewart DA.
Leuk Lymphoma. 2012 Apr;53(4):596-602.
A rapid and simple assay for human blood malignancy engraftment, homing and chemotherapy treatment using fluorescent imaging of avian embryos.
Grinberg I, Dukhovny A, Goldstein RS.
Leuk Lymphoma. 2012 Mar;53(3):472-8. Epub 2011 Nov 15.
The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma.
Andresen S, Brandt J, Dietrich S, Memmer ML, Ho AD, Witzens-Harig M.
Leuk Lymphoma. 2012 Mar;53(3):386-93. Epub 2011 Oct 10.
Long-term survival after allogeneic stem cell transplant for relapsed large B cell lymphomas: a retrospective study.
Lazarevic V, Remberger M, Hägglund H, Juliusson G, Omar H, Halböök H, Kimby E, Malm C, Wahlin A, Johansson JE.
Leuk Lymphoma. 2012 Mar;53(3):503-5. Epub 2011 Nov 15. No abstract available.
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary results.
Anderlini P, Saliba RM, Ledesma C, Chancoco C, Alousi AM, Shpall EJ, Popat UR, Hosing CM, Khouri IF, Nieto Y, Ciurea S, Younes A, Fanale MA, Acholonu S, Valverde R, Champlin RE.
Leuk Lymphoma. 2012 Mar;53(3):499-502. Epub 2011 Oct 24. No abstract available.
Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
Nishiwaki S, Miyamura K.
Leuk Lymphoma. 2012 Apr;53(4):550-6. Epub 2011 Sep 29.
Will cord blood stem cells come to the rescue of keratinocyte growth factor?
Wickrema A.
Leuk Lymphoma. 2011 Aug;52(8):1423-4. No abstract available.
Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma.
Bashir Q, Shah N, Parmar S, Wei W, Rondon G, Weber DM, Wang M, Orlowski RZ, Thomas SK, Shah J, Qureshi SR, Dinh YT, Popat U, Anderlini P, Hosing C, Giralt S, Champlin RE, Qazilbash MH.
Leuk Lymphoma. 2012 Jan;53(1):118-22. Epub 2011 Aug 24.
Intensive chemotherapy without stem cell transplant for indolent lymphomas.
Wendtner CM.
Leuk Lymphoma. 2011 Nov;52(11):2039-40. Epub 2011 Aug 18. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on